Originally introduced as a bone void filler for large orthopedic reconstructive procedures, the new smaller size can be used where smaller amounts of demineralized bone matrix are required.
Read Integra LifeSciences’ release on its Accell Evo3 Demineralized Bone Matrix.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
